US FDA Says Restored Webpages Do Not Reflect ‘Biological Reality’

 
• By Sue Sutter

Clinical trial draft guidance webpages are back online following a court order, but with new language disclaiming any information promoting gender ideology as "extremely inaccurate."

DAP Website with Statement
The clinical trial diversity action plan guidance webpage now includes a disclaimer about "gender ideology." (Screenshot of FDA Website)

More from Diversity & Inclusion

More from Pink Sheet